Literature DB >> 2615526

Evolution of multiple cytogenetic clones and leukemic transformation in a case of myelodysplastic syndrome.

E Donti1, G V Donti, F Falzetti, A Rosetti, F Grignani, A Tabilio.   

Abstract

The cytogenetic follow-up of a case of refractory anemia with excess of blasts (RAEB) that rapidly evolved to acute myeloblastic leukemia (M1-FAB type) is described. Bone marrow analysis at presentation revealed two chromosomally abnormal clones that shared an interstitial deletion of the long arm of chromosome 5 (5q-) and a terminal deletion of the short arm of chromosome 12 (12p-), but that differed from one another in the localization of a very similar segment of chromosome 17 (i.e. 17q11-12qter) on two clearly distinct karyotypic sites: 2q37 and 17q25. Fourteen percent of the metaphases examined bore the 2q+ marker and 38% the 17q+ marker; the remaining cells had a normal karyotype. A second study carried out 4 months later, at onset of the acute phase, revealed that the clone with normal karyotype had almost completely disappeared and that there had been an inversion in the ratio of the two abnormal cell populations. In the final study, made 1 month before death, the cells with t(2;17) had totally effaced the other clone. These findings seem to indicate that, among the karyotypic changes that occurred in an original clone with 5q- and 12p-, only the t(2;17) could have played a crucial role in the final leukemic transformation.

Entities:  

Mesh:

Year:  1989        PMID: 2615526     DOI: 10.1007/bf02985196

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  27 in total

1.  The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia.

Authors:  K S Chang; W Schroeder; M J Siciliano; L H Thompson; K McCredie; M Beran; E J Freireich; J C Liang; J M Trujillo; S A Stass
Journal:  Leukemia       Date:  1987-05       Impact factor: 11.528

2.  Sequential development of distinct clonal chromosome abnormalities in a patient with preleukaemia.

Authors:  B A Miller; H J Weinstein; M Nell; C T Henkle; P L Dillon; R Tantravahi
Journal:  Br J Haematol       Date:  1985-03       Impact factor: 6.998

Review 3.  Chromosome abnormalities in the myelodysplastic syndromes.

Authors:  S Heim; F Mitelman
Journal:  Clin Haematol       Date:  1986-11

4.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

5.  Karyotypic evolution in patients with myelodysplastic syndromes.

Authors:  J Benítez; F Carbonell; J Sanchez Fayos; H Heimpel
Journal:  Cancer Genet Cytogenet       Date:  1985-03-15

6.  Evidence for a multistep pathogenesis of a myelodysplastic syndrome.

Authors:  W H Raskind; N Tirumali; R Jacobson; J Singer; P J Fialkow
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

7.  5q- syndrome terminating in acute myeloid leukemia. Karyotype evolution and immunologic characterization of blast cells.

Authors:  E Donti; A Tabilio; G V Donti; C Mecucci; A Carotti; F Grignani; M F Martelli
Journal:  Cancer Genet Cytogenet       Date:  1988-06

8.  The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.

Authors:  A L Schechter; M C Hung; L Vaidyanathan; R A Weinberg; T L Yang-Feng; U Francke; A Ullrich; L Coussens
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

9.  Human preleukemia.

Authors:  H P Koeffler; D W Golde
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391

10.  Localization of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia.

Authors:  R N Simmers; L M Webber; M F Shannon; O M Garson; G Wong; M A Vadas; G R Sutherland
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.